APO RESEARCH · REPORT
Hemoperfusion
Hemoperfusion is a treatment technique in which large volumes of the patient's blood are passed over an adsorbent substance in order to remove toxic substances from the blood. Adsorption is a process in which molecules or particles of one substance are attracted to the surface of a solid material and held there. These solid materials are called sorbents.
Product & engineering
Understand the product.
Hemoperfusion is a treatment technique in which large volumes of the patient's blood are passed over an adsorbent substance in order to remove toxic substances from the blood. Adsorption is a process in which molecules or particles of one substance are attracted to the surface of a solid material and held there. These solid materials are called sorbents.
Selected research
Industry Research
Hemoperfusion Industry Research Report 2026
Market perspective
Hemoperfusion is a treatment technique in which large volumes of the patient's blood are passed over an adsorbent substance in order to remove toxic substances from the blood. Adsorption is a process in which molecules or particles of one substance are attracted to the surface of a solid material and held there. These solid materials are called sorbents.
China is the largest Hemoperfusion market with about 65% market share. Europe is follower, accounting for about 19% market share.The key manufacturers are Jafron Biomedical, Baxter (Gambro), Asahi-Kasei, Biosun Medical, Kaneka, Toray Medical, Cytosorbents, Aier, Zibo Kangbei etc. Top 3 companies occupied about 81% market share.
Report Scope
Read the full market overview
This report quantifies the global Hemoperfusion market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Hemoperfusion Market by Company
Jafron Biomedical
Baxter (Gambro)
Asahi-Kasei
Biosun Medical
Kaneka
Toray Medical
Cytosorbents
Aier
Zibo Kangbei
Hemoperfusion Segment by Type
Activated Carbon Adsorption
Resin Adsorption
Hemoperfusion Segment by Application
Hepatic Encephalopathy
Certain Autoimmune Diseases
Drug Overdose
Specific Intoxications
Others
Hemoperfusion Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hemoperfusion market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Hemoperfusion and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hemoperfusion.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Hemoperfusion manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Hemoperfusion by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Hemoperfusion in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Activated Carbon Adsorption
- Resin Adsorption
Applications
- Hepatic Encephalopathy
- Certain Autoimmune Diseases
- Drug Overdose
- Specific Intoxications
- Others
Companies covered
- Jafron Biomedical
- Baxter (Gambro)
- Asahi-Kasei
- Biosun Medical
- Kaneka
- Toray Medical
- Cytosorbents
- Aier
- Zibo Kangbei
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Hemoperfusion Market Size (2021-2032)
- 2.2.2 Global Hemoperfusion Sales (2021-2032)
- 2.2.3 Global Hemoperfusion Market Average Price (2021-2032)
- 2.3 Hemoperfusion by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Activated Carbon Adsorption
- 2.3.3 Resin Adsorption
- 2.4 Hemoperfusion by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hepatic Encephalopathy
- 2.4.3 Certain Autoimmune Diseases
- 2.4.4 Drug Overdose
- 2.4.5 Specific Intoxications
- 2.4.6 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Hemoperfusion Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Hemoperfusion Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Hemoperfusion Revenue of Manufacturers (2021-2026)
- 3.4 Global Hemoperfusion Average Price by Manufacturers (2021-2026)
- 3.5 Global Hemoperfusion Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Hemoperfusion, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Hemoperfusion, Product Type & Application
- 3.8 Global Manufacturers of Hemoperfusion, Established Date
- 3.9 Global Hemoperfusion Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Jafron Biomedical
- 4.1.1 Jafron Biomedical Company Information
- 4.1.2 Jafron Biomedical Business Overview
- 4.1.3 Jafron Biomedical Hemoperfusion Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Jafron Biomedical Hemoperfusion Product Portfolio
- 4.1.5 Jafron Biomedical Recent Developments
- 4.2 Baxter (Gambro)
- 4.2.1 Baxter (Gambro) Company Information
- 4.2.2 Baxter (Gambro) Business Overview
- 4.2.3 Baxter (Gambro) Hemoperfusion Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Baxter (Gambro) Hemoperfusion Product Portfolio
- 4.2.5 Baxter (Gambro) Recent Developments
- 4.3 Asahi-Kasei
- 4.3.1 Asahi-Kasei Company Information
- 4.3.2 Asahi-Kasei Business Overview
- 4.3.3 Asahi-Kasei Hemoperfusion Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Asahi-Kasei Hemoperfusion Product Portfolio
- 4.3.5 Asahi-Kasei Recent Developments
- 4.4 Biosun Medical
- 4.4.1 Biosun Medical Company Information
- 4.4.2 Biosun Medical Business Overview
- 4.4.3 Biosun Medical Hemoperfusion Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Biosun Medical Hemoperfusion Product Portfolio
- 4.4.5 Biosun Medical Recent Developments
- 4.5 Kaneka
- 4.5.1 Kaneka Company Information
- 4.5.2 Kaneka Business Overview
- 4.5.3 Kaneka Hemoperfusion Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Kaneka Hemoperfusion Product Portfolio
- 4.5.5 Kaneka Recent Developments
- 4.6 Toray Medical
- 4.6.1 Toray Medical Company Information
- 4.6.2 Toray Medical Business Overview
- 4.6.3 Toray Medical Hemoperfusion Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Toray Medical Hemoperfusion Product Portfolio
- 4.6.5 Toray Medical Recent Developments
- 4.7 Cytosorbents
- 4.7.1 Cytosorbents Company Information
- 4.7.2 Cytosorbents Business Overview
- 4.7.3 Cytosorbents Hemoperfusion Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Cytosorbents Hemoperfusion Product Portfolio
- 4.7.5 Cytosorbents Recent Developments
- 4.8 Aier
- 4.8.1 Aier Company Information
- 4.8.2 Aier Business Overview
- 4.8.3 Aier Hemoperfusion Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Aier Hemoperfusion Product Portfolio
- 4.8.5 Aier Recent Developments
- 4.9 Zibo Kangbei
- 4.9.1 Zibo Kangbei Company Information
- 4.9.2 Zibo Kangbei Business Overview
- 4.9.3 Zibo Kangbei Hemoperfusion Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Zibo Kangbei Hemoperfusion Product Portfolio
- 4.9.5 Zibo Kangbei Recent Developments
5 Global Hemoperfusion Market Scenario by Region
- 5.1 Global Hemoperfusion Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Hemoperfusion Sales by Region: 2021-2032
- 5.2.1 Global Hemoperfusion Sales by Region: 2021-2026
- 5.2.2 Global Hemoperfusion Sales by Region: 2027-2032
- 5.3 Global Hemoperfusion Revenue by Region: 2021-2032
- 5.3.1 Global Hemoperfusion Revenue by Region: 2021-2026
- 5.3.2 Global Hemoperfusion Revenue by Region: 2027-2032
- 5.4 North America Hemoperfusion Market Facts & Figures by Country
- 5.4.1 North America Hemoperfusion Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Hemoperfusion Sales by Country (2021-2032)
- 5.4.3 North America Hemoperfusion Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Hemoperfusion Market Facts & Figures by Country
- 5.5.1 Europe Hemoperfusion Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Hemoperfusion Sales by Country (2021-2032)
- 5.5.3 Europe Hemoperfusion Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Hemoperfusion Market Facts & Figures by Country
- 5.6.1 Asia Pacific Hemoperfusion Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Hemoperfusion Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Hemoperfusion Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Hemoperfusion Market Facts & Figures by Country
- 5.7.1 South America Hemoperfusion Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Hemoperfusion Sales by Country (2021-2032)
- 5.7.3 South America Hemoperfusion Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Hemoperfusion Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Hemoperfusion Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Hemoperfusion Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Hemoperfusion Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Hemoperfusion Sales by Type (2021-2032)
- 6.1.1 Global Hemoperfusion Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Hemoperfusion Sales Market Share by Type (2021-2032)
- 6.2 Global Hemoperfusion Revenue by Type (2021-2032)
- 6.2.1 Global Hemoperfusion Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Hemoperfusion Revenue Market Share by Type (2021-2032)
- 6.3 Global Hemoperfusion Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Hemoperfusion Sales by Application (2021-2032)
- 7.1.1 Global Hemoperfusion Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Hemoperfusion Sales Market Share by Application (2021-2032)
- 7.2 Global Hemoperfusion Revenue by Application (2021-2032)
- 7.2.1 Global Hemoperfusion Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Hemoperfusion Revenue Market Share by Application (2021-2032)
- 7.3 Global Hemoperfusion Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Hemoperfusion Value Chain Analysis
- 8.1.1 Hemoperfusion Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Hemoperfusion Production Mode & Process
- 8.2 Hemoperfusion Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Hemoperfusion Distributors
- 8.2.3 Hemoperfusion Customers
9 Global Hemoperfusion Analyzing Market Dynamics
- 9.1 Hemoperfusion Industry Trends
- 9.2 Hemoperfusion Industry Drivers
- 9.3 Hemoperfusion Industry Opportunities and Challenges
- 9.4 Hemoperfusion Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst